WallStSmart
BIOR

Biora Therapeutics Inc

NASDAQ: BIOR · HEALTHCARE · BIOTECHNOLOGY

$0.22
+0.00% today

Updated 2026-04-30

Market cap
$994990.00
P/E ratio
0.61
P/S ratio
0.74x
EPS (TTM)
$0.36
Dividend yield
52W range
$0 – $0
Volume

WallStSmart proprietary scores

38
out of 100
Grade: D
Sell
Investment rating
5.3
Growth
C+
5.0
Quality
C+
3.5
Profitability
D
8.3
Valuation
A
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$34.00
+15354.55%
12-Month target
$0.22
+0.00%
Intrinsic (DCF)
$0.82
Margin of safety
+73.17%

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 15,800.00% QoQ
+ 73.17% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-8.75M

Key financials

Revenue Net Income Free Cash Flow
Metric2020202120222023TTM
Revenue$74.31M$1.25M$305000.00$4000.00$860000.00
Net income$-192.53M$-178.52M$-38.16M$-124.11M$-18.40M
EPS$0.36
Free cash flow$-170.69M$-168.34M$-65.21M$-48.60M$-8.75M
Profit margin-259.08%-14,316.04%-12,510.49%-3,102,875.00%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
BIOR$994990.00385.33.58.35.0+73.17%Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-26.29%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Biora Therapeutics Inc trades at $0.22. representing a P/E of 0.61x trailing earnings. Our Smart Value Score of 38/100 indicates the stock is weak. TTM revenue stands at $860000.00. Our DCF model estimates intrinsic value at $0.82.

Frequently asked questions

What is Biora Therapeutics Inc's stock price?
Biora Therapeutics Inc (BIOR) trades at $0.22.
Is Biora Therapeutics Inc overvalued?
Smart Value Score 38/100 (Grade D, Sell). DCF value $0.82.
What is the price target of Biora Therapeutics Inc (BIOR)?
The analyst target price is $34.00, representing +15354.5% upside from the current price of $0.22.
What is the intrinsic value of Biora Therapeutics Inc (BIOR)?
Based on our DCF model, intrinsic value is $0.82, a +73.2% margin of safety versus $0.22.
What is Biora Therapeutics Inc's revenue?
TTM revenue is $860000.00.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.74x
ROE
Beta1.28
50D MA$0.22
200D MA$0.22
Shares out0.00B
Float0.00B
Short ratio
Avg volume

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years